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Abstract
Objective: This study aims to use high throughput 16SrRNA gene sequencing to examine the bacterial profile of
lymph node biopsy samples of patients with sarcoidosis and to further verify the association between
Propionibacterium acnes (P. acnes) and sarcoidosis.
Methods: A total of 36 mediastinal lymph node biopsy specimens were collected from 17 cases of sarcoidosis, 8
tuberculosis (TB group), and 11 non-infectious lung diseases (control group). The V4 region of the bacterial 16SrRNA
gene in the specimens was amplified and sequenced using the high throughput sequencing platform MiSeq, and
bacterial profile was established. The data analysis software QIIME and Metastats were used to compare bacterial
relative abundance in the three patient groups.
Results: Overall, 545 genera were identified; 38 showed significantly lower and 29 had significantly higher relative
abundance in the sarcoidosis group than in the TB and control groups (P < 0.01). P. acnes 16SrRNA was exclusively
found in all the 17 samples of the sarcoidosis group, whereas was not detected in the TB and control groups. The
relative abundance of P. acnes in the sarcoidosis group (0.16% ± 0. 11%) was significantly higher than that in the TB
(Metastats analysis: P = 0.0010, q = 0.0044) and control groups (Metastats analysis: P = 0.0010, q = 0.0038). The relative
abundance of P. granulosum was only 0.0022% ± 0. 0044% in the sarcoidosis group. P. granulosum 16SrRNA was
not detected in the other two groups.
Conclusion: High throughput 16SrRNA gene sequencing appears to be a useful tool to investigate the bacterial
profile of sarcoidosis specimens. The results suggest that P. acnes may be involved in sarcoidosis development.
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Background
Sarcoidosis is a systemic granulomatous disease and
often involves the respiratory system. The disease fre-
quently affects middle-aged adults, in particular women
aged 40–50 years. The histopathology of sarcoidosis is
characterized by non-caseous necrotizing granulomas,
and the clinical presentation of the disease is very di-
verse [1]. The exact etiology and pathogenesis of sar-
coidosis remain unclear although several factors, such as
infection [2], genetic defects [3], immune dysfunction
[4], and exposure to environmental pollutants [5], have
been indicated to contribute to sarcoidosis development.
Previous reports studying the association of infection
and sarcoidosis mainly focus on Mycobacterium tuber-
culosis (MTB) and propionibacteria, and show contro-
versial results. Eishi et al. [6] used real-time quantitative
RT-PCR to analyze bacterial DNA in the lymph node bi-
opsy specimens of patients with sarcoidosis, TB, or other
lung diseases and suggested that propionibacteria was
more likely than mycobacterium to be an etiological fac-
tor of sarcoidosis. Contrarily, other reports indicate a
correlation of MTB and sarcoidosis. Oswald et al. [7]
found that the CD4+ and/or CD8+ T cells isolated from
the bronchoalveolar lavage fluid of patients with
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sarcoidosis were more likely than the T cells from the
control patients to be stimulated by mycobacterial
ESAT-6 protein, whereas the response to P. acnes pro-
teins was similar between the T cells of the sarcoidosis
group and the T cells of the control group. Our previous
studies used PCR to determine the copy number of
mycobacteria and propionibacteria in the paraffin-
embedded lymph node biopsy specimens of patients
with sarcoidosis, TB, or other lung diseases and indi-
cated that MTB might not be associated with sarcoidosis
[8] but propionibacteria could be [9].
Most of the previous studies investigated only a few
bacterial species. A full bacterial profile of the tissue
specimens of patients with sarcoidosis is still lacking.
The current study is filling this knowledge gap. In the
current study, we aim to conduct high throughput
16SrRNA gene sequencing to investigate the bacterial
profile of mediastinal lymph node specimens. The
16SrRNA gene is present in the genome of bacteria,
chlamydia, rickettsia, mycoplasma, spirochaeta, and acti-
nomycetes, but absent in eukaryotic organisms, viruses,
and fungus. The sequence of V4 region of the bacterial
16SrRNA gene, which varies greatly in different bacterial
species, is often considered as a unique signature for a
bacterial species and thus commonly used for bacterial
taxonomic classification [10–12]. The V4 region is
flanked by evolutionary conserved regions. In the
current study, the conserved regions were used to design
PCR primers. The V4 region was then amplified by PCR
with the primers and then sequenced. The sequences
were analyzed and compared to the 16SrRNA gene se-
quence database, GreenGene database, by bioinformatics
approaches to identify the bacterial taxonomic annota-
tion [11, 13]. In the current study, we are to use bacterial
16SrRNA gene sequencing to characterize the bacterial
profile of the tissue specimens of patients with sarcoid-
osis and identify the potential pathogenic bacteria that
may correlate with the disease.
Methods
Tissue specimens
The protocol for collecting and handling patients’ biopsy
specimens has been approved by the Institutional Re-
view Board of Shanghai Pulmonary Hospital and Tongji
University School of Medicine (Approval No: 2011-FK-
10). Biopsy specimens from the mediastinal lymph node
of 36 patients, who were treated in Shanghai Pulmonary
Hospital between August 2014 and August 2015, were
collected and analyzed. All the 36 patients, including 17
cases of sarcoidosis, 8 cases of TB, and 11 cases of con-
trol, were inpatients of Shanghai Pulmonary Hospital.
The 8 patients with TB were newly diagnosed based on
positive MTB in their sputum. The 11 controls included
6 cases of nonspecific lymphadenitis and 5 cases of
mediastinal lymph node metastasis of lung cancer. The
clinical data of the patients are displayed in Table 1. All
the participating patients signed the informed consent.
Diagnostic criteria
The diagnostic criteria for sarcoidosis followed the 1999
guidelines of ATS/ERS/WASOG [1]. The histopathology
of lymph node biopsy of the patients with sarcoidosis
was characterized by non-caseous necrotizing granu-
lomas and showed negative TB, fungus and/or parasitic
infection, tumor, and vasculitis. Additionally, to further
confirm sarcoidosis, smear-negative TB was excluded
based on a negative TB-polymerase chain reaction (PCR)
[8] and the comprehensive differential diagnosis scoring
system for sarcoidosis and atypical TB [14]. All the 17
patients with sarcoidosis were followed up for 1 year.
Patients with TB were diagnosed according to the
2013 tuberculosis diagnosis and treatment guidelines
recommended by the China Medical Association Tuber-
culosis Society [15]. The diagnosis of TB was based on
acid-fast bacilli smear-positive sputum, positive Myco-
bacterium tuberculosis (M. TB) in sputum culture, posi-
tive M. TB in bronchopulmonary lavage fluid, or positive
staining for acid-fast bacilli in biopsy specimens. All the
patients with TB underwent anti-TB therapy and cured.
The lymph node biopsy samples of lymphadenitis and
lung cancer metastasis were provided by thoracic sur-
geons of Shanghai Pulmonary Hospital, and the diagno-
sis was confirmed.
Gene sequencing of 16SrRNA
Because the sequence of V4 region of the bacterial
16SrRNA gene is a unique signature of a bacterial spe-
cies, the sequence can be used to identify the specific
bacterial taxonomic position [10]. The V4 region is
flanked by evolutionary conserved regions, which were
used to design PCR primers. The V4 region was then
amplified by PCR with the primers and then sequenced.
Genomic DNA was extracted from the tissue specimens
using the TIANquick FFPE DNA Kit (TIANGEN, China)
according to the instruction of the kit. The genomic
DNA was then used as the template in the PCR to amp-
lify the 16SrRNA gene V4 region (nucleotide position
from 515 to 806). The primer sequences are: 5’-
GTGCCAGCMGCCGCGGTA-3’ (forward primer) and
5’-GGACTACHVGGGTWTCTAAT-3’ (reverse primer).
M stands for nucleotide A or C; H stands for nucleotide
A, C, or T; V stands for nucleotide A, C, or G; W stands
for nucleotide A or T [10]. Phusion® High-Fidelity PCR
Master Mix (New England Biolabs, USA) was used for
PCR reaction. The PCR reaction condition was: initial
denaturation at 98 °C for 1 min; 30 cycles of denatur-
ation at 98 °C for 10 s, annealing at 50 °C for 10 s,
extension at 72 °C for 60 s; final extension at 72 °C for
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5 min. The PCR products were electrophoresed, col-
lected from the gel using the GeneJET Gel Extraction
Kit (Thermo Scientific, USA). The purified PCR prod-
ucts were used to construct a DNA sequencing library
using the the NEB Next® Ultra™ DNA Library Prep Kit
from Illumina (San Diego, CA, USA) according to the
manufacturer’s instruction. The quality of the DNA li-
brary was examined using the Quibit® 3.0 Fluorometer
2.0 (Thermo Fisher Scientific, USA) and Agilent Bioana-
lyzer 2100 system. The DNA library was then sequenced
on the Illumina MiSeq platform (CA, USA). The col-
lected raw sequencing data were processed according to
the following steps: 1) The sequences of Barcode and
primers were first removed from the raw sequencing
data. 2) The sequencing data were then analyzed using
the software FLASH version 1.2.7 (http://ccb.jhu.edu/
software/FLASH/)[16]. For each sample, the sequencing
fragments were aligned and connected to form raw se-
quencing tags. 3) The raw sequencing tags with low
quality sequencing data were removed. 4) The final
sequencing tags were compared against the Genomes
OnLine Database (Gold) database (http://drive5.com/
uchime/uchime_download.html) using the UCHIME Al-
gorithm (http://www.drive5.com/usearch/manual/uchi-
me_algo.html) [17] to identify chimeric sequences. The
chimeric sequences were removed from the final se-
quencing tags [18]. The resulting sequences were the
effective sequencing tags and used for bacterial taxo-
nomic annotation.
Sequence analysis
The identified 16SrRNA sequences (the effective sequen-
cing tags) were annotated using the Uparse software
package v7.0.1001 (http://drive5.com/uparse/) [19]. The
annotation procedure includes the following steps: 1) Se-
quences that share ≥ 97% identity were considered at the
same taxonomic position (belong to the same bacterial
species) and assigned to one operational taxonomic unit
(OTU). 2) The Uparse software automatically selected
representative sequences when constructing OTUs. 3)
The representative sequences were used to annotate the
OTUs. OTUs were annotated with taxonomic informa-
tion using the 16SrRNA gene sequence database, Green-
Gene database, (http://greengenes.lbl.gov/cgi-bin/nph-in
dex.cgi) [20] and the RDP Classifier (Version 2.2, http://
sourceforge.net/projects/rdp-classifier/) [21]. The se-
quences were annotated with taxonomic Kingdom,
Phylum, Class, Order, Family, Genus, and Species. The
relative abundance of each bacterial species in a sample
was also determined by the software.
Statistical analysis
To estimate if the identified 16SrRNA sequences could
include all the bacteria in the samples, we conducted
alpha diversity analysis. The alpha diversity was analyzed
using the Quantitative Insights into Microbial Ecology
(QIIME) software (Version 1.7.0) [22]. To evaluate alpha
diversity, we calculated Chao index representing bacter-
ial species abundance, number of observed species, and








Age, mean ± SD (years) 53.12 ± 7.41 53.55 ± 12.75 45.13 ± 20.73 0.3013
Male/female ratio 3/14 6/5 6/2 N/A
CXR stage: 0/I/II/III/IV number of patients (n) 0/10/4/3/0 N/A N/A N/A
Tuberculosis examination negative/positive (n) 17/0 N/A 0/8 N/A
BMI (kg/m2) 24.74 ± 2.45 22.75 ± 3.87 22.87 ± 2.34 0.1564
SACE (IU/L) 58.47 ± 26.86 (n = 15) N/A N/A N/A
ESR (mm/h) 24.13 ± 15.82 (n = 16) 31.20 ± 19.81 (n = 6) 34.57 ± 39.43 (n = 7) 0.5996
24-h urinary calcium 5.70 ± 2.11(n = 12) N/A N/A N/A
CD3 (%) 66.56 ± 8.07 (n = 14) N/A 58.67 ± 15. 58 (n = 7) 0.1380
CD4 (%) 34. 01 ± 10.15 (n = 14) N/A 35.66 ± 13.03 (n = 7) 0.7526
CD8 (%) 24. 87 ± 10.40 (n = 14) N/A 18.99 ± 4.51 (n = 7) 0.1730
IgG (ng/L) 12.36 ± 2.73 (n = 10) N/A 14.67 ± 7.20 0.3607
IgA (ng/L) 1.96 ± 0.56 (n = 10) N/A 2.73 ± 1.12 0.0734
IgM (ng/L) 1.47 ± 0.77 (n = 10) N/A 1.19 ± 0.73 0.4324
C3 (ng/L) 1.25 ± 0.20 (n = 10) N/A 1.20 ± 0.29 0.6584
C4 (ng/L) 0.31 ± 0.072 (n = 10) N/A 0.34 ± 0.094 0.4571
CXR Chest X-ray. CXR stage 0: no adenopathy and no lung infiltrates; stage I: hilar & mediastinal adenopathy only; stage II: hilar & mediastinal adenopathy plus
lung infiltrates; stage III: lung infiltrates only; stage IV: Pulmonary fibrosis. BMI (Body Mass Index): weight ÷ height2. SACE serum angiotensin converting enzyme.
ESR erythrocyte sedimentation rate. N/A not applicable
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Shannon index representing bacterial community diversity.
Rarefaction curves were plotted using the three parameters
as vertical axes and the number of identified sequences as
horizontal axes. Chao index, number of observed species,
and Shannon index increase as the number of identified se-
quences increases in a sample, which indicates that unique
bacterial species are increasingly identified in a sample. Sat-
uration of the rarefaction curves indicate that the number
of unique bacterial species does not increase as the number
of identified sequences increases, which suggests that the
identified 16SrRNA sequences may cover all the bacteria
in the sample.
Bacterial relative abundance was determined to identify
the most predominant bacterial species, which represent
the bacterial profile in the samples. The Quantitative In-
sights into Microbial Ecology (QIIME) software (Version
1.7.0) and Uparse software package v7.0.1001 (http://
drive5.com/uparse/) were used to analyze bacterial
abundance. The Metastats software (http://metas-
tats.cbcb.umd.edu/) was used to compare the differ-
ence in bacterial abundance between different groups.
The Metastats software is specifically designed to
compare bacterial abundance by quantitatively analyz-
ing the 16SrRNA gene sequences [23].
Intra-group comparison was performed to evaluate the
differences in the bacterial profile of samples in the same
patient group. Inter-group comparison was performed to
estimate the difference in the bacterial profile of the sar-
coidosis, control, and TB patient groups. Because bacter-
ial profile is expected to vary considerably in different
individuals, evaluation of inter- and intra-group differ-
ence may reveal the unique characteristics of bacterial
profile in sarcoidosis, control, and TB patient groups.
For inter-and intra-group comparison of bacterial pro-
file, R software (version 3.1.3) was used for nonparamet-
ric multi-response permutations procedure (MRPP) [24]
and the analysis of similarity (Anosim) [25]. An A value
(calculated from the MRPP) > 0 represented inter-group
difference > intra-group difference; A < 0 represented
inter-group difference < intra-group difference, P < 0.01
was considered statistically significant. An R value (cal-
culated from the Anosim) > 0 represented inter-group
difference > intra-group difference; R < 0 represented
inter-group difference < intra-group difference; P < 0.01
was considered statistically significant. A P value was
first calculated for inter-group difference in relative
abundance. The P value was then adjusted to q value
using an algorithm established by Storey and Tibshirani
[26]. Based on both the P and q values, Taxonomic units
showing significantly different relative abundance in the
three groups were identified. When both P < 0.01 and q
< 0.01, the differences were considered statistically sig-
nificant. The software Graphpad prism 5 was used to
prepare the curves of bacterial relative abundance. The
software SPSS 20.0 was used for chi-square analysis of
the inter-group difference in bacterial positive rate;
P < 0.01 was considered statistically significant.
Results
Patients’ clinical data
Patients in the sarcoidosis, TB, and control groups
showed similar age, body mass index, and erythrocyte
sedimentation rate (Table 1). The majority of patients
(n = 10) with sarcoidosis were at chest X-ray stage I.
The percentages of specific T cell populations, includ-
ing CD3, CD4, and CD8, were similar in the sarcoid-
osis and TB groups. So were the levels of IgG, IgA,
IgM, C3, and C4 (Table 1).
Sequence data and OTUs
Sequencing data are presented in Additional file 1:
Table S1. A total of 8748 unique OTUs were constructed
by the Uparse software, and an average of 1768 unique
OTUs in each sample. The sequences of all the 8748
unique OTUs are displayed in Additional file 2: Table S2.
The OTUs were annotated at phylum, class, order, family,
genus, and species taxonomic levels using the RDP Classi-
fier Version 2.2 (http://sourceforge.net/projects/rdp-clas-
sifier/) and the 16SrRNA sequence database, GreenGene
database (http://greengenes.lbl.gov/cgi-bin/nph-index.cgi).
The annotations of all the 8748 are presented in
Additional file 3: Table S3. At the taxonomic genus
level, a total of 545 unique bacterial genera were
identified in all the samples. The relative abundances
of the 545 bacterial genera in each sample are pre-
sented in Additional file 4: Table S4.
At the taxonomic genus level, the OTUs were assigned
to 545 genera based on the Greengenes database
(Additional file 4: Table S4). In the sarcoidosis group,
478 unique bacterial genera were identified; the top
10 most abundant genera were: Shewanella, Pseudomonas,
Acinetobacter, Lactobacillus, Prochlorococcus, Bifido-
bacterium, Escherichia, Halomonas, Pediococcus, and
Rhodococcus (Table 2). The control group showed
470 unique bacterial genera, including Bacteroides,
J2-29, Prevotella, Methylobacterium, Oscillospira,
[Prevotella], Roseburia, Ruminococcus, Clostridium,
and Helicobacter as the top ten most abundant bac-
terial genera (Table 2). The TB group contained 489
unique bacterial genera, and the most abundant ones
were Bacteroides, J2-29, [Prevotella], Methylobacterium,
Prevotella, Clostridium, Methyloversatilis, Succinivibrio,
Sutterella, and Salinispora (Table 2). All of the most abun-
dant bacterial genera in the three patient groups belonged
to the four bacterial Phylum: Proteobacteria, Firmicutes,
Bacteroidetes, and Fusobacteria.
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Alpha diversity of the sequencing data and the analyses
of intra- and inter-group difference in bacterial profile
The rarefaction curves of number of observed species
(Fig. 1a), Chao index (Fig. 1b), and Shannon index
(Fig. 1c) reach a plateau, suggesting that the identified
sequences may sufficiently cover the bacteria in the sam-
ples. The rank abundance curves (Fig. 1d) also become
stable, indicating that species distribution is uniform.
Both the Anosim and MRPP analyses revealed that the
inter-group difference in bacterial profile was larger than
the intra-group difference and the inter-group difference
was statistically significant (All P < 0.01, Table 3).
Propionibacterium was specifically detected in patients
with sarcoidosis
We compared the relative abundance of each genus in
the three patient groups. A total of 67 bacterial genera
showed significantly higher or lower relative abundance
in the sarcoidosis group compared with the TB and con-
trol groups (P < 0.01, q < 0.01). Among the 67 genera, 38
showed significantly lower relative abundance in the
sarcoidosis group than in the TB and control groups
(P < 0.01, q < 0.01, Table 4), and 29 showed signifi-
cantly higher relative abundance in the sarcoidosis
group than in the TB and control groups (P < 0.01, q
< 0.01, Table 5).
Among the 29 bacterial genera with significantly
higher relative abundance in the sarcoidosis group, The
Propionibacterium Genus was found in all the 17 pa-
tients with sarcoidosis (100% positive rate) but was com-
pletely absent in all the 8 patients with TB (0% positive
rate, χ2 = 25, P < 0.0001) and 11 control patients (0%
positive rate, χ2 = 28, P < 0.0001). In contrast, the other
28 bacterial genera were detected in all the patients in
the three groups, suggesting that these bacterial genera
may not be specific for patients with sarcoidosis. The
relative abundance of the Propionibacterium Genus
in the sarcoidosis group was 0.16% ± 0. 11%, which
was significantly higher than that in the control (0%,
P = 0.001, q = 0.0055) and TB groups (0%, P = 0.0010,
q = 0.0063).
In addition to propionibacteria, mycobacteria [7, 8, 27, 28],
Borrelia [29, 30], mycoplasma [31], and chlamydia [32]
have also been investigated as pathogenic organisms.
Thus, we examined the four microorganisms. Mycobac-
terium was detected in the three patient groups but
showed very low relative abundance. Although the rela-
tive abundance of Mycobacterium in the TB group
(0.077% ± 0.037%) was higher than that in the sarcoid-
osis (0.056% ± 0.029%, P = 0.18, q = 0.38) and control
(0.052% ± 0.073%, P = 0.36, q = 0.94) groups, the differ-
ences was not statistically significant. The relative
abundance of mycoplasma was also very low in the
three groups: 0.0067% ± 0.0090% in the sarcoidosis
group, 0.0026% ± 0.0034% in the control group (P = 0.59,
q = 0.77), and 0.0020% ± 0.0023% in the TB group (P
= 0.19, q = 0.39). The differences were not statistically
significant. Neither Borrelia nor and chlamydia was
detected in the samples.
The two predominant bacterial species in the Propi-
onibacterium Genus are Propionibacterium acnes (P.
acnes) and Propionibacterium granulosum (P. granulo-
sum). P. acnes was detected in all the 17 patients with
sarcoidosis, whereas P. granulosum was detected in only
5 of the 17 patients. Both Propionibacterium species
were not found in the control and TB groups. The rela-
tive abundance of P. acnes in the sarcoidosis group
(0.16% ± 0. 11%) was significantly higher than that in the
control (0%, P = 0.0010, q = 0.0038) and TB (0%, P =
0.0010, q = 0.0044) groups (Fig. 2a). In contrast, the rela-
tive abundance of P. granulosum in the sarcoidosis
group (0.0022% ± 0. 0044%), which was extremely lower
than the relative abundance of P. acnes, was not signifi-
cantly different compared with that in the control (0%,
P = 0.088, q = 0.18) and TB (0%, P = 0.19, q = 0.38)
groups (Fig. 2b). These data indicate that P. acnes may
Table 2 The top ten most abundant bacterial genera of the three patient groups
Sarcoidosis Control disease Tuberculosis
Bacteria Abundance Bacteria Abundance Bacteria Abundance
1 Shewanella 7.33 ± 4.60 Bacteroides 13.13 ± 2.72 Bacteroides 13.32 ± 3.51
2 Pseudomonas 4.32 ± 2.75 J2-29 5.28 ± 3.82 J2-29 8.91 ± 2.15
3 Acinetobacter 3.31 ± 4.46 Prevotella 5.16 ± 2.63 [Prevotella] 3.25 ± 0.89
4 Lactobacillus 3.06 ± 3.98 Methylobacterium 4.11 ± 3.95 Methylobacterium 2.96 ± 2.85
5 Prochlorococcus 2.24 ± 2.83 Oscillospira 3.36 ± 1.92 Prevotella 2.75 ± 1.29
6 Bifidobacterium 1.89 ± 7.05 [Prevotella] 3.16 ± 1.02 Clostridium 2.60 ± 0.25
7 Escherichia 1.09 ± 0.83 Roseburia 2.98 ± 2.02 Methyloversatilis 1.33 ± 1.45
8 Halomonas 1.07 ± 0.71 Ruminococcus 2.65 ± 1.47 Succinivibrio 1.22 ± 0.20
9 Pediococcus 0.97 ± 1.01 Clostridium 2.56 ± 0.42 Sutterella 1.06 ± 0.27
10 Rhodococcus 0.77 ± 0.64 Helicobacter 1.07 ± 0.65 Salinispora 1.01 ± 0.37
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be more likely to correlate with sarcoidosis than other
bacteria. The process of identification of the unique bac-
terium in the sarcoidosis group is displayed in Fig. 3.
Discussion
The association of infection and sarcoidosis etiology has
been studied extensively. Molecular biological ap-
proaches have been used to search bacterial genome in
sarcoidosis lesions [33]. Previous studies have shown
that possible pathogenic organisms for sarcoidosis
include propionibacteria [8, 33, 34], mycobacterium
[7, 8, 27, 28], borrelia [29, 30], mycoplasma [31],
Fig. 1 Alpha diversity. a Number of observed species curves. b Chao index curves. c Shannon index curves. d Rank abundance curves. LN1:
Sarcoidosis group. LN2: Control disease group. LN3: Tuberculosis group
Table 3 Inter-group analysis
Comparing pair Anosim analysis MRPP analysis
R value P value A value P value
Sarcoidosis versus Control 0.9976 0.001 0.2817 0.001
Sarcoidosis versus Tuberculosis 0.9957 0.001 0.2772 0.001
Tuberculosis versus Control 0.4592 0.001 0.09667 0.001
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and chlamydia [32]. Particularly, MTB and propioni-
bacteria are the most frequently reported bacteria
correlating with sarcoidosis [35, 36]. In spite of the
efforts, no consistent and definitive conclusion has
been drawn. Piotrowski et al. reported that MTB in-
fection triggered a sarcoid reaction, and thus they
proposed that TB and sarcoidosis might be different
clinical manifestations of MTB infection [28]. However,
Table 4 The 38 bacterial genera with significantly lower abundance in the sarcoidosis group
Bacteria Genera Sarcoidosis (%) Control (%) Tuberculosis (%) q1 value q2 value
N = 17 N = 11 N = 8
Prevotella 0.26 ± 0.37 5.16 ± 2.63 2.75 ± 1.29 q < 0.01 q < 0.01
Clostridium 0.16 ± 0.14 2.56 ± 0.42 2.60 ± 0.25 q < 0.01 q < 0.01
Parabacteroides 0.018 ± 0.27 0.41 ± 0.13 0.25 ± 0.066 q < 0.01 q < 0.01
Bacteroides 0.12 ± 0.12 13.13 ± 2.72 13.32 ± 3.51 q < 0.01 q < 0.01
Oscillospira 0.12 ± 0.085 3.36 ± 1.92 0.58 ± 0.31 q < 0.01 q < 0.01
Methyloversatilis 0.065 ± 0.11 0.28 ± 0.15 1.33 ± 1.45 q < 0.01 q < 0.01
Methylobacterium 0.11 ± 0.065 4.11 ± 3.95 2.96 ± 2.85 q < 0.01 q < 0.01
Phascolarctobacterium 0.069 ± 0.063 0.84 ± 0.44 0.59 ± 0.20 q < 0.01 q < 0.01
Roseburia 0.055 ± 0.069 2.98 ± 2.02 0.71 ± 0.19 q < 0.01 q < 0.01
Faecalibacterium 0.050 ± 0.059 0.58 ± 0.15 0.58 ± 0.13 q < 0.01 q < 0.01
Ruminococcus 0.052 ± 0.052 0.52 ± 0.14 0.37 ± 0.059 q < 0.01 q < 0.01
Bradyrhizobium 0.054 ± 0.041 0.27 ± 0.093 0.30 ± 0.070 q < 0.01 q < 0.01
Sutterella 0.034 ± 0.037 0.87 ± 0.31 1.06 ± 0.27 q < 0.01 q < 0.01
Megamonas 0.029 ± 0.036 0.54 ± 0.20 0.68 ± 0.18 q < 0.01 q < 0.01
Prevotella 0.024 ± 0.039 3.16 ± 1.02 3.25 ± 0.89 q < 0.01 q < 0.01
Arcobacter 0.018 ± 0.022 0.13 ± 0.054 0.41 ± 0.47 q < 0.01 q < 0.01
Dialister 0.012 ± 0.014 0.076 ± 0.019 0.091 ± 0.022 q < 0.01 q < 0.01
Dorea 0.0095 ± 0.013 0.086 ± 0.057 0.047 ± 0.011 q < 0.01 q < 0.01
Allobaculum 0.0054 ± 0.014 0.36 ± 0.35 0.10 ± 0.042 q < 0.01 q < 0.01
Eubacterium 0.0043 ± 0.0089 0.035 ± 0.014 0.039 ± 0.012 q < 0.01 q < 0.01
Acetobacter 0.0059 ± 0.0071 0.025 ± 0.011 0.028 ± 0.013 q < 0.01 q < 0.01
Succinivibrio 0.0045 ± 0.0077 0.70 ± 0.30 1.22 ± 0.20 q < 0.01 q < 0.01
Mitsuokella 0.0032 ± 0.0063 0.032 ± 0.012 0.033 ± 0.0096 q < 0.01 q < 0.01
Anaerobiospirillum 0.0031 ± 0.0044 0.10 ± 0.037 0.15 ± 0.027 q < 0.01 q < 0.01
Cetobacterium 0.0033 ± 0.0041 0.077 ± 0.077 0.076 ± 0.047 q < 0.01 q < 0.01
Trichococcus 0.0017 ± 0.0045 0.040 ± 0.015 0.074 ± 0.050 q < 0.01 q < 0.01
Flavisolibacter 0.0022 ± 0.0039 0.022 ± 0.029 0.016 ± 0.0084 q < 0.01 q < 0.01
Collinsella 0.0013 ± 0.0039 0.77 ± 0.36 0.79 ± 0.18 q < 0.01 q < 0.01
Brevibacillus 0.0016 ± 0.0032 0.057 ± 0.029 0.082 ± 0.046 q < 0.01 q < 0.01
Peptococcus 0.0012 ± 0.0024 0.052 ± 0.017 0.051 ± 0.012 q < 0.01 q < 0.01
Bilophila 0.00065 ± 0.0022 0.011 ± 0.0043 0.010 ± 0.0064 q < 0.01 q < 0.01
Slackia 0.00068 ± 0.0020 0.035 ± 0.018 0.042 ± 0.018 q < 0.01 q < 0.01
J2-29 0.00065 ± 0.0019 5.28 ± 3.82 8.91 ± 2.15 q < 0.01 q < 0.01
Campylobacter 0.00051 ± 0.0016 0.056 ± 0.016 0.071 ± 0.024 q < 0.01 q < 0.01
Thermicanus 0.00026 ± 0.001 0.013 ± 0.0071 0.018 ± 0.020 q < 0.01 q < 0.01
Paraprevotella 0 ± 0 0.13 ± 0.13 0.018 ± 0.035 q < 0.01 q < 0.01
Phormidium 0 ± 0 0.011 ± 0.018 0.0089 ± 0.012 q < 0.01 q < 0.01
Sporolactobacillus 0 ± 0 0.0093 ± 0.019 0.0074 ± 0.0038 q < 0.01 q < 0.01
q1 value: Sarcoidosis versus Control q value. q2 value: Sarcoidosis versus Tuberculosis q value
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our previous study, which determined the copy number of
MTB in lymph node specimens of patients with TB or sar-
coidosis, suggests that MTB may not be the pathogenic
bacterium of sarcoidosis [8].
Propionibacteria are gram positive anaerobic bacteria
and belong to the normal flora of the skin. Since Abe et
al. first isolated P. acnes from lymph node biopsy speci-
mens of patients with sarcoidosis in 1984 [34], P. acnes
has been suspected to be a pathogenic bacterium for sar-
coidosis. Negi et al. used P. acnes-specific monoclonal
antibodies that react with cell-membrane-bound lipotei-
choic acid (PAB antibody) in immunohistochemistry to
locate P. acnes in the lung tissue and lymph node speci-
mens of patients with sarcoidosis, and they discovered
that the PAB antibodies specifically bound to the
sarcoidosis specimens but did not react with tissues
from patients with non-sarcoidosis disease [33]. We pre-
viously performed a meta-analysis to systematically
review the articles that focused on the association of P.
acnes and sarcoidosis [37], and our results support that
P. acnes is highly likely a pathogen of sarcoidosis.
On the other hand, other studies indicate that P. acnes
may not be associated with sarcoidosis. Ishige et al.
found that 56% – 73% of specimens (lung tissues: 24/43,
mediastinal lymph node specimens: 8/11) from patients
with non-sarcoidosis diseases showed positive P. acnes
culture [38]. Oswald et al. discovered that compared
with the CD4+ and/or CD8+ T cells from the controls,
the T cells from patients with sarcoidosis reacted to
mycobacterial ESAT-6 protein more frequently but
Table 5 The 29 bacterial genera with significantly higher abundance in the sarcoidosis group
Bacteria Genera Sarcoidosis (%) Control (%) Tuberculosis (%) q1 value q2 value
N = 17 N = 11 N = 8
Shewanella 7.33 ± 4.60 0.014 ± 0.015 0.013 ± 0.011 q < 0.01 q < 0.01
Pseudomonas 4.32 ± 2.75 0.12 ± 0.052 0.17 ± 0.080 q < 0.01 q < 0.01
Prochlorococcus 2.24 ± 2.83 0.021 ± 0.034 0.090 ± 0.096 q < 0.01 q < 0.01
Paenibacillus 0.59 ± 2.14 0.012 ± 0.0095 0.010 ± 0.0069 q < 0.01 q < 0.01
Pediococcus 0.97 ± 1.01 0.088 ± 0.095 0.046 ± 0.022 q < 0.01 q < 0.01
Halomonas 1.07 ± 0.71 0.0038 ± 0.0041 0.0053 ± 0.0047 q < 0.01 q < 0.01
Rhodococcus 0.77 ± 0.64 0.012 ± 0.0088 0.011 ± 0.0056 q < 0.01 q < 0.01
Candidatus Portiera 0.46 ± 0.42 0.0029 ± 0.0032 0.0059 ± 0.0037 q < 0.01 q < 0.01
Alteromonas 0.34 ± 0.30 0.0032 ± 0.0036 0.0030 ± 0.0052 q < 0.01 q < 0.01
Idiomarina 0.034 ± 0.59 0.00045 ± 0.0010 0.00033 ± 0.00094 q < 0.01 q < 0.01
Marinomonas 0.30 ± 0.27 0.00020 ± 0.00066 0.00064 ± 0.0012 q < 0.01 q < 0.01
Vibrio 0.21 ± 0.24 0.023 ± 0.011 0.033 ± 0.015 q < 0.01 q < 0.01
Corynebacterium 0.25 ± 0.15 0.075 ± 0.051 0.052 ± 0.011 q < 0.01 q < 0.01
Tolumonas 0.18 ± 0.21 0.0013 ± 0.0019 0.067 ± 0.12 q < 0.01 q < 0.01
HTCC 0.19 ± 0.17 0.0047 ± 0.0041 0.016 ± 0.024 q < 0.01 q < 0.01
Glaciecola 0.13 ± 0.20 0.0016 ± 0.0021 0.0011 ± 0.0015 q < 0.01 q < 0.01
Aliivibrio 0.10 ± 0.20 0.0071 ± 0.012 0.0050 ± 0.0043 q < 0.01 q < 0.01
Swaminathania 0.14 ± 0.15 0.00020 ± 0.00066 0.0011 ± 0.0015 q < 0.01 q < 0.01
Propionibacterium 0.16 ± 0.11 0 ± 0 0 ± 0 q < 0.01 q < 0.01
Micrococcus 0.10 ± 0.16 0.015 ± 0.0071 0.014 ± 0.0071 q < 0.01 q < 0.01
Thalassobius 0.11 ± 0.12 0.013 ± 0.010 0.0073 ± 0.0038 q < 0.01 q < 0.01
Saccharopolyspora 0.096 ± 0.11 0.0028 ± 0.0040 0.0045 ± 0.012 q < 0.01 q < 0.01
Ochrobactrum 0.069 ± 0.056 0.0067 ± 0.0053 0.0097 ± 0.011 q < 0.01 q < 0.01
Weissella 0.060 ± 0.042 0.0038 ± 0.0046 0.0033 ± 0.0038 q < 0.01 q < 0.01
MSBL3 0.050 ± 0.051 0.00021 ± 0.00069 0.00063 ± 0.0012 q < 0.01 q < 0.01
SGSH944 0.039 ± 0.052 0.0013 ± 0.0041 0.00033 ± 0.00093 q < 0.01 q < 0.01
Methylophaga 0.032 ± 0.046 0.0025 ± 0.0040 0.0019 ± 0.0018 q < 0.01 q < 0.01
Thauera 0.029 ± 0.048 0.0011 ± 0.0022 0.0033 ± 0.0052 q < 0.01 q < 0.01
Xanthobacter 0.015 ± 0.013 0.00045 ± 0.00099 0.0013 ± 0.0020 q < 0.01 q < 0.01
q1 value: Sarcoidosis versus Control q value. q2 value: Sarcoidosis versus Tuberculosis q value
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showed similar response to P. acnes proteins [7]. They
also used matrix-assisted laser desorption ionization im-
aging mass spectrometry to locate the ESAT-6 protein
and the P. acnes proteins in the tissue specimens and
found that ESAT-6 signals specifically existed in sarcoid-
osis granulomas, whereas P. acnes signals were distrib-
uted non-specially in the tissues [7]. These studies
suggest that P. acnes may be not involved in sarcoidosis
etiology.
To identify potential pathogenic bacteria of sarcoid-
osis, we previously used quantitative PCR to quantify the
copy number of 16SrRNA gene of P. acnes and P. granu-
losum in the lymph node specimens and found that pro-
pionibacteria existed in 80% of sarcoidosis specimens
but only in 4.5% of TB specimens [9]. To further con-
firm our previous conclusions, in the current study, we
used high throughput 16SrRNA gene sequencing to
investigate the bacterial profile of lymph node specimens
of sarcoidosis, TB, or other lung diseases. Our results
showed that P. acnes were exclusively present in sarcoid-
osis samples, and both P. acnes and P. granulosum were
not detected in the TB and control groups. These find-
ings clearly support that P. acnes is associated with
sarcoidosis.
The possible pathogenic mechanism of P. acnes in
sarcoidosis development has been tested in animal
models. Kouji Iio et al. used heat-inactivated P. acnes
and Freund's complete adjuvant to induce pulmonary
granuloma in mice, and found that the total number
of lymphocytes and the ratio of CD4+ to CD8+ T
cells in the bronchoalveolar lavage fluid of the mice
with pulmonary granuloma were higher than those of
the control mice [39]. Their study suggests that P.
acnes may cause pulmonary allergic inflammation,
which may consequently lead to granuloma. Eishi et
al. also proposed that P. acnes could cause sarcoidosis
by an allergic endogenous infection [40]. P. acnes or
the bacteria-related antigens may interact with the
pattern recognition receptors to stimulate macro-
phages and T cells to release pro-inflammatory fac-
tors, such as IFN-γ, IL-2, TNF-α, and IL-6, which
ultimately disrupts the immune homeostasis in pa-
tients and induces sarcoidosis development [36].
Thus, P. acnes may cause sarcoidosis by interfering in
the immune homeostasis.
Compared with quantitative PCR approach, high
throughput16SrRNA gene sequencing is a more effective
approach to investigate bacterial profile of biopsy speci-
mens and identify the predominant bacterial species in
the specimens. The sequencing approach also allows us
Fig. 2 Comparison of relative abundance of P. acnes and P.
granulosum in the three patient groups. a Relative abundance of P.
acnes. b Relative abundance of P. granulosum
Fig. 3 Identification of the unique bacteria in the sarcoidosis group
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to compare the diversity and relative abundance of bac-
teria in specimens. Although quantitative PCR approach
may be sensitive, low-cost, and fast, the sequencing ap-
proach can produce data for comprehensive analyses,
such as bacterial taxonomy, bacterial diversity, and the
correlation of bacterial profile evolution and sarcoidosis
progression. The current study first used high through-
put sequencing approach to investigate the bacterial
profile in lymph node specimens of patients with
sarcoidosis and to identify that propionibacteria were
exclusively present in the sarcoidosis specimens. The
advantages of the sequencing method include high
throughput, high reproducibility, and high accuracy. The
limitations of the sequencing method include technically
complex and requiring special instrument and software
for the analysis. In addition, the roles of those bacteria
with significantly higher or lower abundance in the
sarcoidosis group compared with the control and TB
groups in the development of sarcoidosis remain un-
clear. Furthermore, the control groups in the current
study included lymph node specimens of patients with
nonspecific lymphadenitis and of patients with medias-
tinal lymph node metastasis of lung cancer, which may
contribute to the highly various bacterial profiles in the
control group. Another limitation of the current study is
that the number of tissue specimens in the current study
was relatively small. We are currently collecting more
samples to further investigate the dynamic evolution of
bacterial profiles in the sarcoidosis lesions at different
disease stages.
Conclusions
The current study used high throughput 16SrRNA gene
sequencing to demonstrate that P. acnes exclusively
existed in the mediastinal lymph node specimens of pa-
tients with sarcoidosis but was absence in the specimens
of patients with TB or other non-infectious lung dis-
eases. These findings indicate that P. acnes may correlate
with sarcoidosis etiology.
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